INDBInternet News Database 2.5 Updated 1 min ago · 293 sources Show or hide images Light or dark

Residual Disease in Spondyloarthritis: What's Being Missed by DMARDs?

1 source1 article First seen Updated United States Truth score 38

Save Like Comments Compare coverage
Image from Medpagetoday

Summary

(MedPage Today) -- In spondyloarthritis (SpA), the wealth of biologic and disease-modifying anti-rheumatic drug (DMARD) options still leaves some patients unsatisfied with their treatment outcomes, most likely due to residual disease. This year...

Description from Medpagetoday.

Who is covering this

  1. Medpagetoday Center Factuality: Mostly factual US
    Residual Disease in Spondyloarthritis: What's Being Missed by DMARDs?

    (MedPage Today) -- In spondyloarthritis (SpA), the wealth of biologic and disease-modifying anti-rheumatic drug (DMARD) options still leaves some patients unsatisfied with their treatment outcomes, most likely due to residual disease. This year...

Comments

Comments need JavaScript.